aerosolized pentamidine and intravenous trimetrexate are investigational agents that show considerable promise , but their role in the therapy of pneumocystis pneumonia will have to be demonstrated in controlled trials .
C0085176
trimetrexate
C1535939
pneumocystis pneumonia